MedTrace Logo

Evaluation of The Safety And Performance of The Freedom Total Knee® System With The PEEK-OPTIMA Femoral Component

NCT03224689 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2021-07-15

No results posted yet for this study

Summary

Prospective, multi-centre, non-comparative, post-market surveillance clinical study

Conditions

  • Osteoarthritis, Knee
  • Rheumatoid Arthritis of Knee
  • Traumatic Arthritis of Knee (Diagnosis)
  • Polyarthritis
  • Fractures, Bone

Interventions

DEVICE

PEEK-Optima Femoral Component

TKA Surgery

Sponsors & Collaborators

  • Maxx Orthopedics Inc

    lead INDUSTRY

Principal Investigators

  • Peter Verdonk, MD, PhD · More Institute, Antwerp, Belgium

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-12-31
Completion
2024-03-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03224689 on ClinicalTrials.gov